How to order if you are a Patient: Thank you for your interest in our testing. Since all our testing must be ordered by a licensed health care practitioner, please have your current healthcare provider contact us so we can set them up with a Vibrant account.

How to order if you are a Provider: If you are a current Vibrant client, please contact or call your local Territory Sales Manager.

If you don’t have an account with Vibrant Wellness, please fill out a Client Application form to get started.


Test for exposure to COVID-19.

Facts about COVID-19

  • The 2019 novel coronavirus disease (COVID-19) is a new virus of global health significance caused by infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • COVID-19 is thought to spread from person to person in close contact through respiratory droplets
  • These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. It is also possible that a person can catch COVID-19 by touching a surface or object that has the virus on it and then touching their own mouth, nose, or possibly their eyes
  • Currently, previous testing for COVID-19 has included only a nasopharyngeal (NP) swab, which is tested for the presence of DNA from the virus

Facts about the Vibrant COVID-19 Panel

  • Vibrant has developed a novel test for COVID-19. Vibrant’s COVID-19 panel is a highly sensitive and accurate finger-prick serum assay for viral antibodies, as materials such as NP swabs and fecal testing swabs are limited to emergency and critical institutions only at this time
  • Our test was internally developed and validated according to FDA EUA requirements. The independent review of this validation by the FDA is pending. This test does not require confirmation by CDC prior to reporting results
  • Vibrant’s COVID-19 ImmuneCheck looks specifically for IgM, IgA, and IgG antibodies against the spike proteins and 4 viral antigens of Covid-19 that will help assess your immunity against this novel virus


Why Test Antibodies to COVID-19?

Antibodies have been found to be highly sensitive biomarkers in infectious disease diagnosis. Previous studies on SARS, MERS, and more recently the ones on SARS-CoV2 have shown IgM antibodies to appear about 3 days from infection and IgG antibodies appear after 8 days. Profiling an individual’s antibody response is the only way to determine infections with few or no symptoms.

Please note:

  • A patient cannot order their own tests
  • A doctor’s requisition is required for all testing
Not Available in New York state
Only healthcare providers licensed in their state may order laboratory testing.

IgM, IgG, and IgA Antibodies to:

  • SARS-CoV-2 Nucleoprotein
  • SARS-CoV-2 Spike Glycoprotein (S1)
  • SARS-CoV-2 Spike Glycoprotein (S2)
  • SARS-CoV-2 Receptor Binding Domain

Quick Interpretation of Results

Advantage of testing all three types of antibodies:

  • The importance of combination IgM, IgG, and IgA detection in conjunction with other tests such as nucleic acid testing in nasal or fecal swabs should provide the best detection sensitivity and allow for better interpretation as below:
  • IgM
  • IgG/IgA
  • NEG
  • NEG
  • Patient may not be infected or in the window of infection if DNA results are positive from NP or fecal swabs. Consider follow up within few days if symptoms persist or refer patient out for a confirmatory NP swab test.
  • POS
  • NEG
  • Patient may be in the early stage of infection
  • POS
  • POS
  • Patient is in the active phase of infection
  • NEG
  • POS
  • Patient may be in the late or recurrent stage of infection

The CDC reports that the following symptoms may appear 2-28 days after exposure:

  • Coughing
  • Fever
  • Shortness of breath
  • Shortness of breath
  • Gastrointestinal distress
    • Diarrhea
    • Abdominal cramping
  • Fatigue
  • Body aches
  • Headaches

In order to place an order for the Vibrant COVID-19 test panel, you must have a provider account with Vibrant America. If you already have an account, please log in to your provider portal here to place orders:


If you do not have a provider account but wish to open one, free of charge, please fill out the form below to create an account so that you may begin ordering:

Recommended Tests to Consider

Wheat Zoomer
Dairy Zoomer
Lectin Zoomer

Regulatory Statement

This test has not been reviewed by the FDA. · Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals. · Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status. · Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.”